ArticleMolecular oncology2024
RETRACTION: CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR-637 and up-regulating SOX10.
Article in Molecular oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retraction: C. Jin, J. Zhao, Z-P. Zhang, M. Wu, J. Li, B. Liu, X-B. Liao, Y-X. Liao, and J-P. Liu, "CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR-637 and up-regulating SOX10," Molecular Oncology 15, no. 2 (2020): 596-622, https://doi.org/10.1002/1878-0261.12830. The above article, version of record published online on 16 December 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Kevin Ryan; FEBS Press; and John Wiley & Sons Ltd. The journal began an investigation following a report from a third party regarding image duplication in Figure 14H between this article and the following articles: Gong et al. [1] and Zhao, et al. [2]. The authors did not respond to requests by the journal and the publisher for original data and an explanation. The retraction has been agreed because the evidence of image duplication across other articles substantially compromises the conclusions of the article. The authors did not respond to our notice of retraction. References [1] H. Gong, Y. Tao, S. Xiao, X. Li, K. Fang, J. Wen, P. He, and Ming, Z. "LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway," Experimental & Molecular Medicine 55 (2023): 831-843, https://doi.org/10.1038/s12276-023-00972-8. [2] Y. Zhao, C. Li, Y. Zhang, and Z. Li. "CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR-495-MET-eIF4G1 translational regulation axis," Cell Death & Disease 13, no. 250 (2022), https://doi.org/10.1038/s41419-022-04686-z.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.